<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="258">
  <stage>Registered</stage>
  <submitdate>23/08/2005</submitdate>
  <approvaldate>25/08/2005</approvaldate>
  <actrnumber>ACTRN12605000214639</actrnumber>
  <trial_identification>
    <studytitle>Reducing brain injury in cardiac surgery</studytitle>
    <scientifictitle>Dual vent circuit cardiopulmonary bypass to reduce ischemic brain injury in cardiac surgery.</scientifictitle>
    <utrn />
    <trialacronym>ReBICS</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Elective cardiac valve repair or repair in the left heart and brain injury.</healthcondition>
    <healthcondition>Cardiac valve disease</healthcondition>
    <conditioncode>
      <conditioncode1>Injuries and Accidents</conditioncode1>
      <conditioncode2>Other injuries and accidents</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2 />
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Randomised controlled participant and assessor blinded study of an investigational dual vent circuit cardiopulmonary bypass technique in elective open heart surgery patients. Pre-operative and up to 6 weeks post-operative clinical assessments and magnetic resonance imaging studies performed.</interventions>
    <comparator>Conventional cardiopulmonary bypass in elective open heart surgery patients.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>New ischemic lesions on post-operative magnetic resonance imaging studies.</outcome>
      <timepoint>6 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Clinical outcome of death, coma, stroke, transient ischemic attack, post-operative encephalopathy and cognitive impairment.</outcome>
      <timepoint>6 weeks </timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Able to give informed consent; neurologically independent; requiring elective cardiac valve replacement or repair in the left heart; able to undergo magnetic resonance imaging.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Concomitant medical conditions making followup over 6 weeks unlikely; hemodynamically unstable; frequent cardiac arrhythmias; mobile atherosclerotic plaque in the aortic arch; overt congestive heart failure.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Opaque envelopes containing intervention allocation,</concealment>
    <sequence>Computer generated random allocation in blocks.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2 / Phase 3</phase>
    <anticipatedstartdate>1/07/2005</anticipatedstartdate>
    <actualstartdate>4/07/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate>21/01/2012</actualenddate>
    <samplesize>144</samplesize>
    <actualsamplesize>97</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Auckland City Hospital</primarysponsorname>
    <primarysponsoraddress>Park Rd, Grafton
Auckland 1001
New Zealand</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Neurological Foundation of New Zealand</fundingname>
      <fundingaddress>66 Grafton Rd, Grafton 1010
Auckland 
New Zealand</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>National Heart Foundation of New Zealand</fundingname>
      <fundingaddress>PO Box 17160. Greenlane
Auckland 1546
New Zealand</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the study is to investigate whether a newly developed cardiopulmonary (heart) bypass technique, reduces brain injury as a complication of the surgery, compared with conventional cardiopulmonary bypass techniques.</summary>
    <trialwebsite />
    <publication>Barber PA, Hach S, Tippett LJ, Ross L, Merry AF, Milsom P. Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke. 2008;39(5):1427-33. 

Barber PA, Tippett LJ, Merry AF, Hach S, Frampton C, Milsom P. Post-operative ischemia and cognitive impairment in cardiac surgery patients. Ann Thoracic Surgery. 2009;87(2):673-4.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern X Health and Disabilities Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>31/05/2004</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Dr P Alan Barber</name>
      <address>Department of Medicine
Grafton Campus
The University of Auckland
Private Bag 92019
Auckland 1142
New Zealand</address>
      <phone>+6499236520</phone>
      <fax>+6493677146</fax>
      <email>a.barber@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Dr P Alan Barber</name>
      <address>Department of Medicine
Grafton Campus
The University of Auckland
Private Bag 92019
Auckland 1142
New Zealand</address>
      <phone>+6499236520</phone>
      <fax>+6493677146</fax>
      <email>a.barber@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>P Alan Barber</name>
      <address>Department of Medicine
Grafton Campus
The University of Auckland
Private Bag 92019
Auckland 1142</address>
      <phone>+6499236520</phone>
      <fax>+6493677146</fax>
      <email>a.barber@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Peter Alan Barber</name>
      <address>Department of Medicine
Grafton Campus
The University of Auckland
Private Bag 92019
Auckland 1142
New Zealand</address>
      <phone>+6599236520</phone>
      <fax />
      <email>a.barber@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>